Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

ACADIA Pharmaceuticals Company Profile (NASDAQ:ACAD)

Consensus Ratings for ACADIA Pharmaceuticals (NASDAQ:ACAD) (?)
Ratings Breakdown: 9 Buy Rating(s), 1 Strong Buy Rating(s)
Consensus Rating:Buy (Score: 3.10)
Consensus Price Target: $42.85 (34.07% upside)

Analysts' Ratings History for ACADIA Pharmaceuticals (NASDAQ:ACAD)
Show:
DateFirmActionRatingPrice TargetDetailsShare
3/26/2015Vetr Inc.UpgradeBuy -> Strong-Buy$40.64ViewTweet This Rating  Share This Rating on StockTwits
3/12/2015Piper JaffrayReiterated RatingOverweight$39.00ViewTweet This Rating  Share This Rating on StockTwits
3/12/2015Jefferies Group LLCLower Price TargetBuy$50.00 -> $47.00ViewTweet This Rating  Share This Rating on StockTwits
3/12/2015Needham & Company LLCLower Price TargetBuy$40.00 -> $38.00ViewTweet This Rating  Share This Rating on StockTwits
3/10/2015HC WainrightReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
2/27/2015Needham & Company LLCSet Price TargetBuy$40.00ViewTweet This Rating  Share This Rating on StockTwits
2/27/2015JMP SecuritiesBoost Price TargetOutperform$31.00 -> $50.00ViewTweet This Rating  Share This Rating on StockTwits
2/27/2015Needham & Company LLCReiterated RatingBuy$40.00ViewTweet This Rating  Share This Rating on StockTwits
2/24/2015HC WainrightInitiated CoverageBuy$50.00ViewTweet This Rating  Share This Rating on StockTwits
2/6/2015Roth CapitalReiterated RatingBuy$42.00ViewTweet This Rating  Share This Rating on StockTwits
1/28/2015Jefferies Group LLCBoost Price TargetBuy$42.00 -> $50.00ViewTweet This Rating  Share This Rating on StockTwits
12/22/2014Needham & Company LLCBoost Price TargetBuy$26.00 -> $40.00ViewTweet This Rating  Share This Rating on StockTwits
11/21/2014Cowen and CompanyInitiated CoverageOutperform$46.00ViewTweet This Rating  Share This Rating on StockTwits
5/15/2014Morgan JosephInitiated CoverageOverweightViewTweet This Rating  Share This Rating on StockTwits
5/15/2014JPMorgan Chase & Co.Initiated CoverageOverweight$33.00ViewTweet This Rating  Share This Rating on StockTwits
3/4/2014Jefferies Group LLCBoost Price Target$26.00 -> $38.00ViewTweet This Rating  Share This Rating on StockTwits
10/7/2013Ned Davis ResearchInitiated CoverageNeutralViewTweet This Rating  Share This Rating on StockTwits
8/8/2013Roth CapitalBoost Price TargetBuy$20.00 -> $23.00ViewTweet This Rating  Share This Rating on StockTwits
8/7/2013Ladenburg ThalmannBoost Price TargetBuy$15.00 -> $24.00ViewTweet This Rating  Share This Rating on StockTwits
8/7/2013Needham & Company LLCBoost Price TargetBuy$16.00 -> $26.00ViewTweet This Rating  Share This Rating on StockTwits
8/7/2013MLV & Co.DowngradeBuy -> Hold$18.00 -> $20.00ViewTweet This Rating  Share This Rating on StockTwits
6/14/2013JMP SecuritiesBoost Price TargetBuy$16.00 -> $27.00ViewTweet This Rating  Share This Rating on StockTwits
5/8/2013Needham & Company LLCReiterated RatingBuy$16.00ViewTweet This Rating  Share This Rating on StockTwits
5/6/2013Jefferies Group LLCReiterated RatingBuy -> Positive$18.00ViewTweet This Rating  Share This Rating on StockTwits
4/12/2013JMP SecuritiesBoost Price TargetMarket Outperform$9.00 -> $16.00ViewTweet This Rating  Share This Rating on StockTwits
4/12/2013Jefferies Group LLCBoost Price TargetBuy$13.00 -> $18.00ViewTweet This Rating  Share This Rating on StockTwits
4/11/2013MLV & Co.Boost Price TargetBuy$12.50 -> $18.00ViewTweet This Rating  Share This Rating on StockTwits
4/11/2013Roth CapitalBoost Price TargetBuy$15.00 -> $20.00ViewTweet This Rating  Share This Rating on StockTwits
4/11/2013Piper JaffrayUpgradeNeutral -> OverweightViewTweet This Rating  Share This Rating on StockTwits
4/11/2013Needham & Company LLCBoost Price TargetBuy$9.00 -> $16.00ViewTweet This Rating  Share This Rating on StockTwits
4/11/2013Ladenburg ThalmannBoost Price TargetBuy$9.00 -> $15.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 3/30/2013 forward)